PAVmed Inc. 13D and 13G filings for Lucid Diagnostics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-12-12 4:30 pm Unchanged |
2024-11-22 | 13D | Lucid Diagnostics Inc. LUCD |
PAVmed Inc. PAVM |
31,302,444 52.700% |
0 (Unchanged) |
Filing |
2024-02-20 4:45 pm Sale |
2024-02-15 | 13D | Lucid Diagnostics Inc. LUCD |
PAVmed Inc. PAVM |
31,302,444 65.200% |
-3,331,747![]() (-9.62%) |
Filing |
2024-02-02 5:11 pm Purchase |
2024-01-26 | 13D | Lucid Diagnostics Inc. LUCD |
PAVmed Inc. PAVM |
34,634,191 72.200% |
3,331,771![]() (+10.64%) |
Filing |
2022-12-02 5:22 pm Purchase |
2022-11-30 | 13D | Lucid Diagnostics Inc. LUCD |
PAVmed Inc. PAVM |
31,302,420 73.700% |
3,375,230![]() (+12.09%) |
Filing |
2021-10-27 5:26 pm Purchase |
2021-10-18 | 13D | Lucid Diagnostics Inc. LUCD |
PAVmed Inc. PAVM |
27,927,190 75.500% |
27,927,190![]() (New Position) |
Filing |